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     ABSTRACT 
 
BACKGROUND & AIMS: Levobupivacaine is a pure S-enantiomer of 
bupivacaine and it has similar anaesthetic profile with racemic bupivacaine but 
reduced toxic potential. 
  We conduct the present study to evaluate and compare the 
intraoperative haemodynamics and onset and duration of sensory and motor 
blockade. 
METHODS: After clearance from ethics committee, single blinded randomized 
study carried out on ASA-PS І & ІІ patients, undergoing elective upper limb 
surgeries under supraclavicular block, were randomly assigned two groups 
GROUP A – supraclavicular block with 0.5% Bupivacaine ( 0.4ml/Kg) 
GROUP B – supraclavicular block with 0.5% Levobupivacaine ( 0.4ml/Kg) 
RESULTS: The duration of sensory and motor blockade was prolonged with 
levobupivacaine. The onset of sensory and motor blockade and intraoperative 
haemodynamics were same as bupivacaine. Complete failure and toxicity were 
not reported in both groups. 
CONCLUSION: Levobupivacaine is safer and longer acting local anaesthetic 
and its clinical profile is similar to racemic bupivacaine with reduced toxicity.  
 1 
INTRODUCTION 
Peripheral nerve blocks provide ideal operating condition 
when used in optimal conditions. They reduce the stress response 
and least interfere with the vital physiological functions of the body 
compared to conventional techniques. Adequately administered 
regional anaesthesia not only provide excellent intraoperative pain 
relief but also give best post operative analgesia. 
When we trace regional anaesthesia origin, Dr. Carl Koller, a 
young ophthalmologist, employed a cocaine solution for topical  
corneal anaesthesia in patients undergoing eye surgeries in 1884. 
Most of the local anaesthetic agents developed in the first half of 
twentieth century ( 1900-1940) were basically ester compounds. 
They lost their importance due to their short duration of action, 
systemic toxicity and associated allergic reactions. These paved the 
way for the synthesis of newer agents namely amide type of local 
anaesthetic agents. 
Brachial plexus block was first performed by William Stewart 
Halsted
1
 in 1889. He directly exposed the brachial plexus in the 
neck to perform the block using cocaine. Hirschelfirst performed 
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the percutaneous approach of brachial plexus block. Kulenkampf 
was the first to perform the classical supraclavicular approach to 
the brachial plexus block. Then Winnie and Collins  introduced the 
subclavian perivascular block. Raj was the first to perform the 
brachial plexus block through infraclavicular approach. Accardo 
and Adriano first to introduce the axillary approach. 
On subsequent days, regional blocks have been performed 
using nerve stimulation, anatomical landmarks and of fascia clicks. 
Blind blocks that rely solely on anatomical landmarks are known to 
produce serious complications. Even the nerve stimulation 
technique, recommended as the gold standard for nerve 
identification in regional blocks over the past decade fails to ensure 
an adequate level of nerve block. It also carries a risk of damage to 
nerve structures by direct puncture. 
Ultrasound visualisation of anatomical structures offers safe 
block of superior quality by optimal needle positioning. La Grange 
and colleagues in 1978  were the first to perform the 
supraclavicular block through ultrasound blood flow detector. 
Stephen kapral et al in 1994 published the first reported use of 
direct sonographic visualisation for regional anaesthesia. However 
dramatic progress has been madeover the past ten years.  
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The present study was designed to compare ultrasound guided 
supraclavicular block using bupivacaine andlevobupivacaine in 
patients undergoing elective upper limb surgeries. 
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AIM OF THE STUDY 
To compare  ultrasound guided supraclavicular block using 
bupivacaine  or levobupivacaine in patients undergoing elective 
upperlimb surgery with respect to, 
1) Intra operative hemodynamics , 
2) To  compare onset and duration of sensory and motor 
blockade 
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PHYSIOLOGY OF NERVE CONDUCTION 
The human nervous system consists of billions of neurons and 
supporting cells(neuroglial-astrocytes, oligodendrocytes and 
microglial cells for central nervous system and Schwann cells for 
peripheral nervous system). Neurons are able to respond to stimuli 
(such as touch, sound, light and so on), conduct impulse and 
communicate with each other (and with other types of cells like 
muscle cells). 
The nucleus of a neuron is located in the cell body. Extending 
out from the cell body are processes called dendrites and axons. 
These processes vary in number and relative length but always 
serve to conduct impulses. 
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ANATOMY OF NERVES
2
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Each nerve contains both afferent and efferent nerve fibers 
.They are bundled into one or more fascicles and organized within 
three tissue layers:epineurium, perineurium, endoneurium. 
Individual nerve fiber is surrounded by endoneurium, each fascicle 
surrounded by perineurium and finally epineurium encases group of 
fascicles. These three layers act as barriers to passive diffusion of 
local anaesthetics. 
Each nerve fiber is differentiated by presence or absence of 
myelin sheath. Myelinated nerve fiber are surrounded by Schwann 
cells in peripheral nervous system and by oligodendrocytes in the 
central nervous system. The myelin sheath is not a continuous 
sheath, it is interrupted at short, regular intervals by specialized 
regions called nodes of Ranvier. Nerve impulse conduct in 
myelinated nerve fibers by saltatory conduction. 
Nerve fibers are classified according to their size, velocity , 
function and local anaesthetic susceptibility.  
SODIUM ION CHANNEL    
Sodium channels are integral membrane proteins which 
conduct sodium ions through a cell’s plasma membrane. They are 
classified according to the trigger that opens the channels either 
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voltage change ( voltage gated ) or binding of substance ( ligand 
gated )  to the channel. 
Sodium channel consists of a large α subunit and a small β 
subunit. The α subunit has four domains (D1 – D4),  each 
containing six membrane spanning segments, labelled S1 through 
S6. The S4 segment act as voltage sensor. The extracellular portion 
of pore is formed by S5 and S6, which is the most narrow part of 
the channel and is responsible for ion selectivity. The intracellular 
portion of the pore is formed by S6 segment of the four domains. 
The region linking domains 3 and 4 is important for inactivating the 
channel. 
Sodium channel can exist in any three distinct 
states:deactivated (closed), activated (open) and inactivated 
(closed) . 
REFRACTORY PERIOD
3
 
Refractory period of a cell is the period of time during which 
the cell cannot respond to  further stimuli.It is divided into two 
types-absolute refractory period and relative refractory period. 
Absolute refractory period is one during which a second 
stimulus (no matter how much strong stimulus) cannot produce 
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second action potential. Its duration is typically just a millisecond 
or less. It corresponds to depolarisation and part of  repolarisation.  
Relative refractory period is one during which a second 
stimulus (if the stimulus is greater than the threshold potential) can 
produce  action potential. Its duration is several milliseconds. It 
corresponds to the remaining part of  repolarisation and 
hyperpolarisation. 
ALL OR NONE LAW 
It is a principle which states that a muscle or nerve fibre 
either responds completely (when the stimulus is  above the 
threshold potential) or none at all. Amplitude of the response does 
not depend on the strength of stimulus 
ELECTROPHYSIOLOGY 
RESTING MEMBRANE POTENTIAL ( RMP ) 
Transmission of electric nerve impulse along the cell 
membrane forms the basis of signal transduction along nerve fiber. 
Resting membrane potential means unequal distribution of ions on 
the two sides of the nerve cell membrane.The resting membrane 
potential is  approximately -60 to -70mV in neurons ( the 
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extracellular electric potential is by convention taken as zero). It is 
maintained by  
1) Difference in intra and extracellular concentration of sodium 
and potassium which is maintained by active Na-K pump. 
2) Increased permeability of potassium ions compared to sodium 
ions ( potassium leak ).  
ACTION POTENTIAL 
 
An action potential is a very rapid change in membrane 
potential that occurs when a nerve cell membrane is st imulated. 
When a stimulus, above the threshold level, reaches the nerve cell 
membrane, it causes the ions move back and forth to raise the 
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resting membrane potential (-70mV) to more positive values 
(+30mV) in a few milliseconds to produce action potential.  
The sequences of action potential are as follows 
1) When a stimulus ( chemical or electrical ) reaches the nerve 
cell membrane , it causes  some sodium channels to open so 
that resting membrane potential reaches the threshold level ( 
generally 5 – 15 mV less negative than resting potential ). But 
the stimulus should be above the threshold stimulus. 
2) When nerve cell membrane reaches the threshold level , it 
causes more sodium channels to open allowing more sodium 
ions rush into the cell so that the charges across the the 
membrane completely reverse .  By which the threshold level 
reaches  peak level ( -55mV to +30 ). 
3) The peak level voltage of the action potential causes the gated 
sodium channels to close and potassium channels to open. 
Potassium ions move outside the membrane and sodium ions 
stay inside the cell membrane to repolarize the cell.  
4) Due to more repolarization the neuron enters hyperpolarized 
state. In this state more potassium ions are on outside than 
 12 
sodium ions are on inside. this causes cell’s potential to drop 
slightly lower than the resting potential. 
5) Finally neuron’s sodium-potassium pump goes back to work 
which causes three sodium ions push outside the membrane  
and two potassium ions pull inside the membrane so that 
neuron reaches the resting potential. 
 
IMPULSE CONDUCTION 
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An impulse is simply the movement of action potential along the 
neuron cell. When  action potential occurs, the particular area is 
depolarized. As a result, adjacent areas have opposite charges which 
means depolarized areas have more positive charges on inside and 
negative charges on outside the membrane where as adjacent areas have 
more negative charges on inside and positive charges on outside the 
membrane. It develops a mini circuit on the membrane between these 
oppositively charged areas. In other words electron flow between these 
areas. The process repeats itself , action potential reaches the end bulb. 
Conduction velocity depends upon the diameter of fiber and 
the presence or absence of myelin. Speed of conduction is 1 to 120 
 14 
meters per second. Myelinated fibers conduct the impulse more 
faster than non myelinated fibers. 
In myelinated nerve fibers ions can pass only through nodes 
of Ranvier as it lacks myelin which acts as insulator preventing ion 
movement in the rest of the nerve fibre. This results in jumping of 
action potential from one node of Ranvier to another node only. 
These process is called ‘saltatory conduction’.  
IMPULSE TRANSMISSION 
When an action potential reaches the end bulb, the membrane 
become more permeable to calcium ions. Calcium influx causes 
vesicles move toward the synaptic cleft. Vesicles fuses with pre 
synaptic membrane and release their neurotransmitter ( process 
called exocytosis ). Neurotransmitter gets attached to its receptor  
on the post synaptic membrane and produce the response. If enough 
neurotransmitter is released or enough sodium ions enter into the 
cell, action potential will propagate over post synaptic membrane. 
Of course, if insufficient neurotransmitter is released, action 
potential will not be propagated. The neurotransmitter are then 
quickly taken back into presynaptic terminal via transporters or 
destroyed by the enzymes in the synaptic cleft.     
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ANATOMY OF BRACHIAL PLEXUS
4
 
 
The brachial plexus contributes both motor and sensory 
supply of the upperlimb. So brachial plexus has been called as 
‘spinal of the arm’. 
The brachial plexus is mainly derived from the ventral rami of 
lower four cervical nerves (C5 – C8) and first thoracic nerve roots 
(T1). Approximately 15% of patients the plexus is mainly derived 
from C4 – C8 which is called as ‘prefixed plexus’ or from C6 – T2 
which is is called as ‘postfixed plexus’. These variations are usually 
associated with presence of cervical rib or an anomalous first rib.   
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The brachial plexus is divided into five parts. There are Roots, 
Trunks, Divisions, Cords and Branches. There are five terminal 
branches – musculocutaneous nerve , axillary nerve , ulnar nerve , 
median nerve and radial nerve. There are some preterminal and 
collateral branches which leave along its length at various points. 
The nerve roots of the plexus typically comprise a large 
fascicle. These then become polyfascicular due to division and 
recombination along the full length of plexus. Simply, the number 
of fascicle increases and their cross sectional area decreases, from 
proximal to distal in the plexus. 
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ROOTS 
The anterior rami of C5,C6,C7,C8 and T1 forms the ‘roots’ of 
the plexus. These five spinal nerves exit from the intervertebral 
foramina and lie on a sulcus in the respective vertebral transverse 
process . This sulcus is present between anterior and posterior 
tubercle which gives origin to anterior and medial scalene muscle 
respectively. 
The dorsal scapular nerve arise from C5 root which supplies 
rhomboids muscle. The long thoracic nerve ( also called nerve of 
Bell ) arise from C5 ,C6 and C7 roots which supplies to serratus 
anterior musle. 
TRUNKS 
The five nerve roots unite to form three nerve trunks – upper , 
middle and lower . The upper two nerve roots ( C5 & C6 ) unite to  
form upper trunk , C7 root continues as middle trunk and the lower 
nerve roots ( C8 & T1 ) unite to form lower trunk. The five roots 
travel in anterior and medial direction and then become sandwiched 
between scalenus anterior and medius to form three trunks.  
The nerve to subclavius and suprascapular nerve arise from 
upper trunk. The suprascapular nerve contributes sensory 
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innervations to shoulder joint and motor innervations to 
supraspinatus and infraspinatus muscles. 
DIVISIONS 
At the lateral border of first rib each trunk bifurcates into 
anterior and posterior divisions. It is situated posterior to the 
clavicle. Generally anterior division supply flexor muscles or 
ventral aspect of upper limb while posterior division supply 
extensor muscles or dorsal aspect of upperlimb. 
CORDS 
The anterior division of upper and middle trunk unite to form 
lateral cord, the anterior division of lower trunk forms medial cord 
and the posterior division of all three trunks unite to form posterior 
cord. The cords are labelled according to their relationship with 
axillary artery behind the pectoralis minor muscle. 
BRANCHES 
The lateral cord gives three branches – Lateral part of median 
nerve , Musculocutaneous nerve , Lateral pectoral nerve.  
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The medial cord gives five branches – Medial part of median 
nerve , Medial cutaneous nerve of arm , Medial cutaneous nerve of 
forearm , Medial pectoral nerve  and ulnar nerve. 
The posterior cord gives important five branches – Upper 
subscapular nerve , Lower subscapular nerve , Nerve to latissimus 
dorsi ( thoracodorsal nerve ) , Axillary nerve and Radial nerve.  
THE RELATIONS OF THE BRACHIAL PLEXUS 
ROOTS 
The roots of the brachial plexus emerge from intervertebral 
foramina and lie in the sulcus between anterior and posterior 
tubercles and then it lies between scalenus anterior and medius 
muscle. It lies above the second part of subclavian artery.  
TRUNKS 
In the neck, the brachial plexus lies in the posterior triangle 
which is bordered by clavicle , sternocleidomastoid muscle and 
trapezius muscle. It is covered by skin, platysma and deep fascia. It 
is crossed by supraclavicular nerves, inferior belly of omohyoid, 
external jugular vein and transverse cervical artery.  
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The upper and middle trunk lie above the subclavian artery 
but the lower trunk lie behind the artery. These three trunks may 
groove the first rib immediately posterior to the subclavian groove.  
THE INTERSCALENE SHEATH 
As the roots emerge between the transverse process tubercles, 
they lie in a fibrofatty space between two layers of fibrinous sheath. 
Anterior and posterior tubercle is the origin for scalenus anterior 
and medius respectively. Posterior part of the sheath arise from 
posterior tubercle and covers the front of scalenus medius while the 
anterior part of sheath arise from anterior tubercle and covers the 
posterior aspect of scalenus anterior. The sheath extends into the 
axilla around the plexus. Significance of this space is that the local 
anaesthetic can be injected at various sites by interscalene, 
subclavian perivascular  or the axillary approach. 
SUMMARY 
The composition of brachial plexus can be summarized as 
follows 
1) Branches from the roots 
a. Nerve to the serratus anterior 
 21 
b. Twig to phrenic nerve 
c. Dorsal scapular nerve 
2) Branches from trunks 
a. suprascapular nerve 
b. nerve to subclavius 
3) branches from cords 
a. A)lateral cord 
b. lateral pectoral nerve  
c. musculocutaneous nerve 
d. lateral head of median nerve 
4) B)medial cord 
a. medial pectoral nerve 
b. medial cutaneous nerve of arm 
c. medial cutaneous nerve of forearm 
d. medial head of median nerve 
e. ulnar nerve 
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f. posterior cord 
i. upper subscapular nerve 
ii. lower subscapular nerve 
iii. nerve to lattisimus anterior 
iv. axillary nerve 
v. radial nerve 
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PHARMACOLOGY OF BUPIVACAINE 
AND LEVOBUPIVACAINE
5
 
Bupivacaine and Levobupivacaine are amide type of long 
acting local anaesthetic agents. They block nerve conduction in 
sensory and motor nerves largely by interacting with voltage 
sensitive sodium channels on the cell membrane,though potassium 
and calcium channels are also blocked. 
The dose of levobupivacaine is expressed as base whereas the 
dose of racemate bupivacaine is expressed as hydrochloride salt. 
This gives rise to approximately 13% more active substance in 
levobupivacaine solutions compared to bupivacaine. 
STRUCTURE 
Bupivacaine is piperidinecarboxamide 1-butyl –
N(2,6dimethyl phenyl) monohydrochloride , a white odourless, 
crystalline powder that is freely soluble in water. It is homologue of 
mepivacaine (addition of butyl group to the piperidine nitrogen of 
mepivacaine results in bupivacaine) and is chemically related to 
lidocaine.. 
Bupivacaine is chiral drug which has asymmetric carbon atom 
which exhibits a stereoisomerism. Bupivacaine is racemic mixture 
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of both S and R enantiomers ( 50:50 mixture ) where as 
Levobupivacaine is the S enantiomer of  bupivacaine. So 
levobupivacaine has less neurotoxicity and cardiotoxicity than 
bupivacaine. 
MECHANISM OF ACTION 
Local anaesthetics block the generation and conduction of the 
nerve impulse presumably by 
 Increasing the threshold for electrical excitation in the nerve 
 Slowing the nerve impulse propagation 
 Reducing the rate of rise of action potential 
At cellular level, local anaesthetics block sodium 
conductance by 
 Binding of local anaesthetics to internal gate ( H gate ) on 
sodium channels at inactivated closed state to prevent opening 
of the channels by inhibiting the conformational changes  
 They produce nonspecific membrane expansion which means 
unfolding of membrane protein with consequent obstruction 
of sodium channel. 
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In general, the action of local anaesthetic is related to  
 Diameter of the nerve fibre 
 Myelination status of the nerve  
 Conduction velocity 
The order of loss of nerve function is as follows  
 Pain 
 Temperature 
 Touch 
o Proprioception 
 Skeletal muscle tone 
 
Properties Lignocaine Bupivacaine Levobupivacaine 
Potency 1 4 4 
Onset RAPID SLOW SLOW 
pK 7.9 8.1 8.1 
Protein Binding 70 95 >97 
Lipid Solubility 2.9 28 28 
Vd 91 73 55 
Duration in PNB 60-180 240-960 840-1020 
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PHARMACOKINETICS 
A local anaesthetic pharmacokinetic parameters can be 
significantly altered by 
 Presence of hepatic or renal disease 
 Addition of epinephrine 
 Factors affecting urinary pH 
 Renal blood flow 
 Route of drug administration 
 Age of the patient 
ABSORPTION 
The rate of systemic absorption of local anaesthetic is 
dependent upon 
 Dose 
 Concentration 
 The route of administration 
 Vascularity of administration site 
 Presence or absence of epinephrine 
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METABOLISM 
Amide type of local anaesthetics are metabolized primarily in 
the liver by dealkylation and hydroxylation through CYP3A4 and 
CYP1A2 isoforms to give N-desbutylbupivacaine and 
hydroxylbupivacaine respectively. Other metabolic pathways 
includes amide hydrolysis and conjugation with glucuronic acid. 
Due to its basic nature, alpha1-acid glycoprotein is the binding 
protein whose concentration is increased in some clinical situations 
including postoperative trauma. 
EXCRETION 
Poor water solubility of these drugs limit their excretion 
through kidney. But their metabolites can be measured in urine 
after certain hours of peripheral nerve blockade. 
LUNG EXTRACTION 
High doses or unintentional intraarterial injection may lead to 
rapid entry of local anaesthetics into pulmonary circulation. This 
pulmonary extraction will limit the amount of drug entering into 
systemic circulation. But for bupivacaine and levobupivacaine 
pulmonary extraction process saturates rapidly. So it has limited 
role in these drugs. 
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ADVERSE REACTIONS 
Bupivacaine cause some adverse reactions which may be due 
to overdosage, unintentional intravascular injection or slow 
metabolic degradation. 
CVS TOXICITY 
Rapid entry of local anaesthetics into systemic circulation 
cause depression of myocardium, decreased cardiac output, AV 
heart block, hypotension, bradycardia, ventricular arrhythmia 
including ventricular tachycardia and ventricular fibrillation and 
cardiac arrest. Physiological changes (such as in pregnancy) and 
concomitant drug theraphy ( β blockers, digitalis preparations, 
calcium channel blockers ) make patients more vulnerable to 
cardiotoxicity. 
Levobupivacaine has less cardiotoxicity and successful 
resuscitation is more likely. 
CNS TOXICITY 
After rapid entry of local anaesthetics into systemic 
circulation, it readily cross the blood brain barrier due to high lipid 
solubility. It is characterised by depression followed by excitation, 
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restlessness, anxiety, dizziness, tinnitus and blurred vision. Other 
CNS effects include nausea, vomiting, chills and constriction of 
pupils. 
Skeletal muscle twitching in face and extremities may 
proceeding to convulsion. It occurs due to inhibition of inhibitory 
neurons or inhibition of inhibitory neurotransmitters such as 
gamma amino butyric acid(GABA). CNS toxicity depends on the 
rate of increase of drug in systemic circulation than total amount of 
drug injected. 
ALLERGIC REACTION 
Amide type of local anaesthetics rarely cause allergic type of 
reaction. But ester type of local anaesthetics cause allergic reaction 
due to their metabolite para amino benzoic acid. Preservative in 
these drugs such as methyl parabene or similar substances may 
cause allergic reaction. But it depends on prior sensitization and 
antibody production. 
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MANAGEMENT OF LOCAL ANAESTHETIC 
EMERGENCIES  
To avoid these toxicity, slow administration is advisable.  
1) Stop the drug immediately 
2) Ventilate the lungs with 100% oxygen 
3) Assess the haemodynamics 
4) CVS toxicity  
o cardiac arrest – start CPR as per ACLS   guidelines 
o arrhythmia – consider antiarrythmic drugs except class  Īb 
drugs – bretylium 20mg/kg or amiodarone 5mg/kg i.v 
o AV block – conider cardiac pacing 
5) CNS toxicity  
Hyperventilate the lungs and administer benzodiazepines such 
as midazolam or diazepam i.v. If seizure persists, consider 
ultrashort acting barbiturate thiopentone 
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BASICS OF ULTRASOUND
6
 
Ultrasound is the sound with frequency above 20KHz where 
as the audible range of frequency are 20Hz to 20KHz. For 
diagnostic purpose, ultrasound is used with frequency above 2MHz.  
When ultrasound is propagated through medium, it creates a 
regular pressure variation with alternating areas of compression and 
rarefaction. Compression means areas of high amplitude or high 
pressure where as  Rarefaction means low pressure zones. 
Ultrasound is expressed as ‘sine’ waves. 
PROPERTIES 
Wavelength: It is the distance between two areas of 
compression or rarefaction  
Frequency: It is the number of wavelength that pass per unit time.   
Propagation Velocity: It is the speed at which sound waves 
propagate through medium. Velocity depends on tissue density and 
compressibility. 
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   V = λ f 
     λ- wavelength 
     f- frequency 
propagation velocity of some media are 
Air              –  330 ms 
Water         –  1490 ms 
Blood         –  1570 ms 
Soft Tissue – 1540 ms 
Bone           –  4080 ms 
Metal          –  5850 ms 
INTERACTION OF ULTRASOUND WITH TISSUES 
Ultrasound waves interact with media which are expressed as 
attenuation, reflection, refraction, diffraction and scattering.  
Attenuation: It means absorption of ultrasound energy when 
it passes through medium and is converted into heat as  well as 
reflection, refraction and scattering. When attenuation increases, 
penetration through medium will decrease. It is increased by  
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1) High frequency transducer 
2) Increase acoustic impedance mismatch (less 
homogenous medium) 
3) Increase distance from transducer 
Reflection: Ultrasound waves are reflected from the medium 
to the transducer which forms the basis of ultrasound imaging. It 
depends on the difference in acoustic impedance .  
Acoustic impedance depends on density (ρ) and velocity (v) 
of the medium. 
          Z = ρ v 
Acoustic impedance mismatch means large difference in 
acoustic impedance . 
Reflection Coefficent ( R ) = ( Z1-Z2 ) / ( Z1+Z2) 
[Z1 and Z2 are acoustic impedance of two medium] 
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Substances Attenuation Impedance 
Water 0.002 1.48 
Blood 0.18 1.61 
Soft Tissue 0.75 1.65 
Air 12 0.0001 
Bone 20 8 
Metal 0.2 47 
 
TRANSDUCERS : 
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Ultrasound waves are generated by piezoelectric crystals. 
Piezoelectric means pressure-electric effect. When electric current 
is passed through the crystals, they change their polarity and shape 
of crystals which produces compression and rarefaction of 
ultrasound waves. The reverse is also true. The reflected echoes 
passed through crystals, they generate electric current and it forms 
the image in the screen. Hence crystals are both transmitter and 
receiver. The specific crystals determine the frequency of 
ultrasound wave. 
FRESNEL AND FRAUNHOFER ZONE : Standard disc 
shaped transducer produces beam in cylindrical shape. The waves 
travel parallel to each other to some extent. It is near field or 
Fresnel zone. Beyond that, beam becomes divergent and reduces 
the resolution. It is far field or Fraunhofer zone. 
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RESOLUTION 
Resolution means the ability to differentiate or distinguish the 
adjacent structures. It is divided into two types 
1) Spatial resolution 
a. Axial resolution 
b. Lateral resolution 
2) Temporal resolution 
Axial Resolution : It means ability to distinguish the objects 
at slightly different depths from the transducer along the axis of the 
beam. It is improved by higher frequency transducer. 
Axial resolution = spatial pulse length / 2 
SPL = λ * no of cycles 
Lateral Resolution : It means ability to distinguish the 
objects side by side perpendicular to the beam axis. It depends upon 
beam width. To optimise the lateral resolution 
 Use higher frequency transducer 
 Optimise focal zone 
 Use minimum necessary gain 
Temporal Resolution : It depends on frame rate. 
ARTEFACTS  
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The ultrasound machine makes various assumption when it 
generates an image. The various types of artefacts are 
 Reverberation artefact 
 Side lobe artefact 
 Beam width artefact 
IMAGING 
Short Axis Imaging  
The probe is held perpendicular to the direction of target 
structures. 
Long Axis Imaging 
The probe is held along the direction of target structures.  
 
Needle Imaging 
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In Plane Imaging  
It refers needle is directed in the same plane as ultrasound beam. 
Out of plane imaging 
It refers needle is directed perpendicular to the plane of 
ultrasound beam. 
 
Key Components 
Key components to improve needle imaging are 
 In plane imaging 
 Position of patient 
 Low needle angle 
 Make small needle movements and probe 
 Hydrodissection  
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POTENTIAL ADVANTAGES OF ULTRASOUND GUIDANCE 
REGIONAL ANAESTHESIA 
 Increased success rate due to direct visualisation 
 Direct and indirect visualisation of spread of local 
anaesthesiaduring injection with the possibility of 
repositioning of needles in case of maldistribution of local 
anaesthetic 
 Avoidance of inadvertent intraneural and intravascular 
injection 
 Faster onset and longer duration of blocks 
 Reduction of dose of local anaesthetic  
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SUPRACLAVICULAR BLOCK 
Surgery of upper extremity can be achieved by various 
techniques of brachial plexus blockade. Brachial plexus gives 
number of branches along their course so that by selecting the 
appropriate technique, we can block the site of surgery and spare 
other areas. The various approaches are 
1) Interscalene block 
2) Supraclavicular block – classic approach, plumb bob 
technique, supraclavicular perivascular technique 
3) Infraclavicular block 
4) Axillary block 
5) Peripheral block – midhumeral, elbow, wrist block 
Among these techniques, supraclavicular block is simple and  
easy and less complicated than others. Supraclavicular block targets 
trunks-divisions level of brachial plexus. Typical features of this 
block includes rapid onset, predictability and dense anaesthesia. We 
can approach supraclavicular block through various techniques 
1) Landmark based Supraclavicular perivascular technique 
2) Nerve stimulator guided supraclavicular block 
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3) Ultrasound guided supraclavicular block 
Indications for supraclavicular block are operation on 
midhumerus, elbow, forearm and hand. Distal trunk-proximal 
division of brachial plexus the site for supraclavicular block.  
LANDMARK BASED SUPRACLAVICULAR BLOCK
7
 
TECHNIQUES 
After checking the emergency equipment and securing the 
intravenous line, intravenous fluids, ECG, pulse oxymeter, blood 
pressure monitor are connected. 
Asepsis is done by draping the blockade site with betadine or 
any antiseptic solution and sterile sheath is covered on blockade 
site. Patient is sedated with benzodiazepines or opioid compounds.  
1) Position: Patient is placed in supine position and head turned 
45degrees opposite to the side to be blocked. The 
anaesthesiologist stands behind the patient facing the arm to 
be blocked. The arm kept along the body with elbow flexed 
and hand extended and placed over the abdomen. The neck 
should be extended by keeping a towel behind the scapula if 
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possible or elevating the patient headend by 45 degrees ( 
semisitting position ). 
2) Identification of Groove: The lateral border of 
sternocleidomastoid muscle is palpated by asking the patient 
to raise the head with same turned position. Then with the 
palpating finger the anterior scalene muscle is rolled over to 
identify the interscalene groove. The scalene muscle can be 
identified by asking the patient to sniff. Then palpate the 
subclavian artery behind the clavicle and mark should be 
made behind the posterior border of pulsatile artery site or 1.5 
to 2 cm behind the clavicle blindly. 
3) Needling: First skin and subcutaneous is infiltrated with 2% 
lignocaine. A 22gauge, 4cm needle is directed towards 
inferoposterior direction with slight medial angulation. The 
needle should be proceeded until paraesthesia or motor 
response is elicited. If paraesthesia is elicited, syringe is 
attached and blood is aspirated before giving a  local 
anaesthetic solution. This orientation of syringe lie parallel to 
the line joining needle entry site and the patient ear. Usually 
paraesthesia can be elicited in 35-40mm depth.        
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If paraesthesia cannot be elicited, redirect the needle. If rib is 
encountered, needle shall be walked over the rib anteriorly and 
posteriorly or medially with caution or laterally until paraesthesia 
is elicited. If artery is encountered, needle should be withdrawn and 
reinserted in posterolateral direction until paraesthesia is elicited. 
For this block 30-40ml of local anaesthetic solution is adequate. 
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COMPLICATIONS 
1) Pneumothorax 
2) Phrenic nerve block 
3) Horner syndrome 
4) Neuropathy 
5) Haemothorax and haematoma formation  
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NERVE STIMULATOR GUIDED SUPRACLAVICULAR 
BLOCK 
Nerve stimulator delivers a current (charge) to the nerve fibre 
eliciting motor response due to flow of ions through nerve cell 
membrane and initiation of action potential. If the delivered current 
is larger, the maximal motor response is reached. The variables of 
current are duration and intensity. The intensity of current depends 
upon impedance of tissues in between and distance between 
stimulating surface ( needle or catheter ) and nerve. 
Position and identification are similar to blind landmark 
based technique. A 21gauge, 35 or 40 mm needle is inserted 
through interscalene groove behind the subclavian artery. After 
entering the fascicular sheath by fascial pop, the stimulating current 
is set as 1mA, 2MHz and 0.1ms. If the muscle response is achieved, 
reduce the current intensity to 0.35mA. If the muscle response is 
persistent, local anaesthetic solution can be given. 
Some muscle response indicates incorrect needle location. It 
includes diaphragmatic contraction (phrenic nerve – too anterior 
position) and contraction of posterior compartment of shoulder 
(suprascapular nerve – too posterior position) 
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ULTRASOUND GUIDED SUPRACLAVICULAR BLOCK
8
 
The key requirement for regional anaesthesia is local 
distribution of local anaesthetic around nerve structure. The goal is 
most effectively achieved under sonographic visualization. 
Ultrasound shows ‘real time’ imaging  so that nerve structure and 
position, needle entry and local anaesthetic solution distribution 
can be best visualised under sonographic guidance. 
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TECHNIQUES 
1) Position: Patient is placed in supine position and head turned 
by 45 degrees opposite to the side to be blocked. The 
anaesthesiologist stands behind the patient on the side the 
arm is to blocked. The arm kept along the body with elbow 
flexed, hand extended and placed over the abdomen. The neck 
should be extended by keeping a towel under the scapula if 
possible or elevating the patient head end by 45 degrees ( 
semisitting position ). The ultrasound transducer, screen, 
needle and plane of imaging should be placed before the 
operator on same side. 
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2) Ultrasound Settings: The 38mm linear array probe is set at 
high frequency ( 5 – 12 MHz ) to identify the relevant 
structures. The transducer should be held between index and 
thumb finger while little finger and ulnar aspect of hand rest 
on the neck. Scanning mode, gain and depth of field are 
optimized. 
3) Sonoanatomy: Ultrasound gel is applied over transducer. 
Transducer is placed on supraclavicular fossa after 
identifying hyperechoic clavicle bone. Then identify 
hyperechoic first rib  and hyperechoic pleura beneath it. Then 
identify the pulsatile hypoechoic subclavian artery superficial 
to first rib. Brachial plexus is found superficial and lateral to 
subclavian artery as multiple hypoechoic structures ( honey 
comb appearance ) and then colour Doppler is applied to 
know the vessels if present in between the nerves before 
needle is inserted. Brachial plexus and subclavian artery lie 
between two scalene muscles. Transducer shall move from 
lateral to medial ( coronal oblique to transverse view ) for 
tracing the brachial plexus and confirmation. Brachial plexus 
is found as hypoechoic linear structure in interscalene groove.  
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4) Technique :   
After checking the emergency equipment and securing the 
intravenous line, intravenous fluids, ECG, pulseoxymeter, blood 
pressure monitor is connected. 
Asepsis is achieved by draping the blockade site with 
betadine and sterile sheath is covered around blockade site.  
After identify the brachial plexus, skin and subcutaneous 
wheal is raised at lateral aspect of the transducer with 2% 
lignocaine. Needle is inserted over skin wheal. Needle goes parallel 
to the ultrasonic beam with short angle as inplane approach. Needle 
bevel should face upwards towards the ultrasonic transducer. It 
improves the visibility of needle tip. A 21gauge, 50mm needle is 
inserted parallel to ultrasonic beam. The needle tip is advanced 
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slowly under real time imaging towards brachial plexus neural 
structures. If needle tip goes out of plane imaging, manipulate the 
transducer or redirect the needle. But manipulating the transducer is 
always preferred over redirection of needle because of patient 
discomfort. 
Once the needle tip is close to the brachial plexus structures 
under real time viewing, test injection of 2ml of 0.5% bupivacaine 
is injected to assess the spread around structures after aspiration for 
blood. If local anaesthetic is not seen on the screen, stop the 
injecting solution and readjust the needle to complete encirclement 
of full volume of  local anaesthetic around brachial plexus. Local 
anaesthetic solution appear as hypoechoic structure. 
If nerve stimulator is available, it improves confirmation of 
neural structure. The combination of ultrasound and nerve 
stimulator confirmation improves the success rate of 
supraclavicular block. 
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COMPLICATIONS  
1) Neuropathy – it is devastating complication  
Etiology  : mechanical injury (needle trauma), nerve edema, 
haematoma, pressure effect of local anaesthesia injectate and 
neurotoxicity of injecting solution .  confounding factors are pre-
existing neuropathies (diabetic neuropathy), surgical manipulation, 
compression from post operative casting and prolonged tourniquet 
pressure. 
Classification – 1: Neuropraxia – mild insult in which both 
the axon and  the connective tissue supporting it remain intact. 
Axonotmesis – axonal interruption with preservation of 
connective tissue. Regeneration occurs at rate 2mm/day. Recovery 
is favourable but not complete. 
Neuronotmesis – complete fascicular interruption including 
axon and connective tissue. Recovery is poor even after surgical 
reapproximation of two stumps. 
Prevention - pain on injection, injection pressure monitoring 
( injection pressure >20psi is specific sign of infrafascicular needle 
tip placement ). 
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MANAGEMENT  
 Good communication is essential both for patient comfort and 
medicolegal problems 
 Most of the sensory changes will resolve within 4-6 weeks. 
 Evaluate the surgical cause. 
 If motor deficit is present or complete , severe neuropathy is 
present should be seen immediately by neurophyscician or 
neurosurgeon. 
2)  Pneumothorax, phrenic nerve palsy, horner syndrome and 
artery or any structural injury have lower incidence than 
blind method. 
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REVIEW OF LITERATURE 
Regional anaesthesia is a well accepted modality of 
anaesthesia  to achieve clinical and economic benefits to patients in 
the perioperative period. It includes intraoperative surgical 
anaesthesia, postoperative analgesia, early ambulation after surgery 
and less incidence of thromboembolic and cardiac events. But there 
is aninherent failure rate even in best hands in regional anaesthesia. 
The reason behind that is variation in human anatomy exist and 
structures deep inside  are identified by  human anatomical 
landmarks.  
Peripheral nerve block performed with blind techniques has 
failure rate of 20%.Our main aim is distribution of local anaesthetic 
solution around nerves and that drugs block the nerve effectively. 
Ultrasonography satisfies the first aim by provide a real time 
imaging of nerve structures and local anaesthetic distribution . So 
that minimum volume of drugs are enough to block the nerves 
effectively. 
1) Winnie and Ramamoorthy (1977) postulated that drugs block 
the nerves from peripheral (mantle) to central (core) fibres. 
Thus order of blockade is as follows: loss of motor power of 
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arm, loss of sensation of arm, loss of motor power to the 
forearm and loss of sensation to the hand. 
2) Lanz et al (1983) experimented the extent of blockade using 
various techniques of brachial plexus block. They concluded 
that subclavianperivascular approach of Winnie resulted in 
homogenous blockade of brachial plexus. 
3) Stephan Kapral et al (1994) investigated 40 patients with the 
use of ultrasound guidance for supraclavicular brachial plexus 
block. They concluded that ultrasound guided approach 
combines the safety of axillary block with  larger extent of 
block of the supraclavicular block. 
4) Perlas A et al (2009) conducted a study on 510 patients who 
received ultrasound guided supraclavicular block. They 
concluded that ultrasound guided supraclavicular block is 
associated with high success rate and a low rate of 
complications. 
5) Cox et al (1998) conducted a clinical study to compare S(-) 
bupivacaine with racemic bupivacaine in supraclavicular 
block by nerve stimulator technique. They concluded that 
there is no significant difference between groups in onset and 
 55 
duration of sensory and motor blockade and demonstrated 
that S(-) bupivacaine has reduced toxic potential compared 
with bupivacaine. 
6) ShaliniSardesai et al (2014) conducted a clinical study 
between bupivacaine and levobupivacaine by ultrasound 
guided supraclavicular block. They concluded that 
levobupivacaine was safer, had rapid onset and longer action 
than bupivacaine and block quality was similar to 
bupivacaine. 
7) Jose Riccardi et al (2009) conducted comparative clinical 
study between bupivacaine and levobupivacaine by nerve 
stimulator techniques. They demonstrated that anaesthetic 
quality of levobupivacaine is similar to that of racemic 
bupivacaine. 
8) Smyrna et al conducted comparative study of 
levobupivacaine and bupivacaine in axillary brachial plexus 
block and concluded levobupivacaine has rapid sensory and 
motor onset time without significant difference in block 
duration. 
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9) Dr.Chaur J Pandya compared analgesic  and anaesthetic 
property of levobupivacaine with bupivacaine. They 
concluded levobupivacaine has similar clinical profile as 
bupivacaine however safety profile of levobupivacaine 
confers an advantage over racemic bupivacaine. 
10) Cacciapuoti et al (2002) evaluated the clinical profile of 
levobupivacaine, bupivacaine and ropivacaine in brachial 
plexus block. They concluded levobupivacaine is as effective 
as racemic bupivacaine with longer duration of sensory block 
and quicker surgical onset and in comparison with 
ropivacaine, levobupivacaine showed similar onset but longer 
duration of sensory and motor block. 
11) CenkIlham et al (2014) conducted efficiency study of 
levobupivacaine and bupivacaine by nerve stimulator 
technique. They concluded that bupivacaine lead to faster 
sensory and motor onset compared to levobupivacaine 
however had similar duration of postoperative analgesia.  
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       MATERIALS AND METHODS 
After obtaining ethics committee approval, this study was 
carried out in the orthopaedic surgery theatre, Rajivgandhi 
Government General Hospital, Chennai. The aim of the study was 
to compare ultrasound guided supraclavicular block using 
bupivacaine or levobupivacaine in patients undergoing elective 
upperlimb surgeries. 
STUDY DESIGN 
A prospective, randomised study conducted on 60 ASA PS І 
& ІІ presenting for elective upper limb surgeries under 
supraclavicular block who fulfil the inclusion criteria.  
After getting the written informed consent from all patients, 
they were randomly assigned to two groups 
TWO GROUPS 
Group-A: Preoperative ultrasound guided supraclavicular block 
with 0.5% bupivacaine ( 0.4ml/Kg) 
Group-B: Preoperative ultrasound guided supraclavicular block 
with 0.5% levobupivacaine (0.4ml/Kg) 
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INCLUSION CRITERIA 
 Age : 18 years and above 
 Weight : BMI < 30 Kg/m2 
 ASA : I & II 
 Surgery : Elective 
 Mallampatti  scores : I & II 
 Who have given valid informed consent. 
EXCLUSION CRITERIA  
 Not satisfying inclusion criteria.  
 Patients posted for emergency surgery 
 Patients with difficult airway 
 Lack of written informed consent 
 Pregnant female 
 H/O seizures and any neurological deficit 
 Severe renal , hepatic, respiratory or cardiac disease 
 Severe coagulopathy 
 Allergy to local anaesthetic drugs 
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PRIMARY OUTCOME MEASURES  
 Systolic blood pressure, diastolic blood pressure, mean 
arterial pressure and heart rate changes during intra 
operative period. 
 Onset and duration of sensory and motor blockade 
SECONDARY OUTCOME MEASURES  
 Post operative opioid requirements 
MATERIALS 
 Ultrasonic machine 2D & 7.5-11 MHz ultrasonic 
scanning probe 
 21G , 50mm  needle 
 Drugs –inj.bupivacaine, inj. Levobupivacaine 
 Monitors – ECG,NIBP,SPO2. 
 Equipments and drugs for resuscitation 
 Equipments and drugs for conversion to general 
anaesthesia in the case of block failure 
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METHODS 
Pre Operative Preparation 
Patients were preoperatively assessed and obtained written 
informed consent after explaining the procedure to the patient. 
Pre Medication 
Tab.ranitidine 150mg 2 hours before surgery with sips of water. 
CONDUCT OF ANAESTHESIA 
On arrival of the patient to the operating theatre, standard 
monitors like ECG, non invasive blood pressure and pulse oximeter 
were commenced and baseline values were recorded. A 18G 
intravenous line was established in the opposite arm and infusion 
started with Ringer lactate solution or normal saline solution.  
PROCEDURE 
1) Position : Patient is placed in supine position and head turned 
by 45 degrees opposite to the side to be blocked. The 
anaesthesiologist stands behind the patient on the side the 
arm is to blocked. The arm kept along the body with elbow 
flexed, hand extended and placed over the abdomen. The neck 
should be extended by keeping a towel under the scapula 
which brings scapula and humerus forward if possible or 
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elevating the patient head end by 45 degrees ( semisitting 
position ) and push the pillow behind the patient head to 
opposite side and away from working area. These two steps 
are to create a space in which needle can be manipulated 
easily. The ultrasound transducer, screen, needle and plane of 
imaging should be placed before the operator on same side.  
2) Ultrasound Settings: The 38mm linear array probe is set at 
high frequency ( 7.5-11 MHz ) to identify the relevant 
structures. The transducer should be held between index and 
thumb finger while little finger and ulnar aspect of hand rest 
on the neck. Scanning mode, gain and depth of field are 
optimized. 
3) Sonoanatomy : Ultrasound gel is applied over transducer. 
Transducer is placed on supraclavicular fossa after 
identifying hyperechoic clavicle bone. Then identify 
hyperechoic first rib  and hyperechoic pleura beneath it. Then 
identify the pulsatile hypoechoic subclavian artery superficial 
to first rib. Brachial plexus is found superficial and lateral to 
subclavian artery as multiple hypoechoic structures ( honey 
comb appearance ) and then colour Doppler is applied to 
know the vessels if present in between the nerves. Brachial 
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plexus and subclavian artery lie between two scalene muscles. 
Transducer shall move from lateral to medial ( coronal 
oblique to transverse view ) for tracing the brachial plexus 
and confirmation. Brachial plexus is found as hypoechoic 
linear structure in interscalene groove. 
4) Technique  
After checking the emergency equipment and securing the 
intravenous line, intravenous fluids, ECG, pulseoxymeter, blood 
pressure monitor is connected. 
Asepsis is achieved by draping the blockade site with 
betadine and sterile sheath is covered around blockade site.  Sterile 
ultrasonic gel is applied over transducer and then transducer is 
placed in sterile cover to prevent air trapping. 
Transducer is placed on the supraclavicular fossa just behind 
the center of the clavicle and orientate the side marker towards the 
medial side of clavicle. Then drift the lateral part of transducer 1cm 
away from the clavicle. This will allow some movement to help 
align the transducer and needle. Then identify the structures by 
sonoanatomy. 
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 After identifying the brachial plexus, skin and subcutaneous 
wheal is raised at lateral aspect of the transducer with 2% 
lignocaine. Needle is inserted over skin wheal. Needle should go 
parallel to the ultrasonic beam with steep angle as ‘in plane’ 
approach. Needle bevel should face upwards parallel to the 
ultrasonic beam. It improves the visibility of needle tip. A 21gauge, 
50mm needle is inserted parallel to ultrasonic beam. The needle tip 
is advanced slowly under real time imaging towards brachial plexus 
neural structures. If needle tip goes out of plane imaging, 
manipulate the transducer or redirect the needle. But manipulating 
the transducer is always preferred over redirection of needle 
because of patient discomfort. 
Once the needle tip is close to the brachial plexus structures under 
real time viewing, test injection of 2ml of 0.5% bupivacaine or 
levobupivacaine is injected to assess the spread around structures after 
aspiration for blood. If local anaesthetic is not seen on the screen, stop the 
injecting solution and readjust the needle to confirm the position. 
Group A patients receive bupivacaine solution (0.4ml/Kg) where as 
Group B patients receive levobupivacaine solution (0.4ml/Kg). 
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EVALUATION OF THE BLOCK 
The following observation were made 
 Vital signs monitoring: heart rate, non invasive blood pressure and 
oxygen saturation were measured every 5 minutes until the end of 
surgery. For statistical purpose, we were documented at 0, 5, 10, 
15, 30minutes and every 30 minutes thereafter. 
 After administering  the drug, patients were evaluated for the 
onset of sensory and motor blockade every minute.  
 Onset of sensory block evaluated by using surgical spirit 
soaked cotton in the dermatome C4-T2. 
 Onset of motor block evaluated by shoulder flexion and 
extension, forearm flexion and extension, thumb and second 
digit pinch and thumb and fifth digit pinch. Only patient with 
complete motor block are included in the study. Failure of the 
block to be concluded after 20 minutes. 
 Onset of sensory block time was the time to first loss of 
temperature sensation in any dermatome with time 0 min 
being the time completion of injection. 
 Onset of motor block time was the time to first loss of motor 
power of any muscular compartment 
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 Duration of sensory block was the time from onset to 
complete recovery of sensation 
 Duration of motor block was the time from onset to complete 
recovery of motor power 
 Assessment of sensory and motor block were carried out 
every 30 minutes in  postoperative period 
 Quality of block was assessed by three point scale 
Grade 0 – complete failure 
Grade 1 – unsatisfactory block  
  [Inadequate analgesia 
  Inadequate relaxation 
  Require GA because of agitation or restlessness] 
Grade 2 – satisfactory block 
 After confirmation that the block was taken up, patient 
sedated with Inj.Midazolam 1-2mg 
 Local anaesthetic toxic reactions and complication associated 
with the technique were looked for. 
All the data were subjected to statistical analysis.  
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OBSERVATION AND RESULTS 
TREATMENT GROUPS 
Treatment 
Groups 
Group Names Treatment 
Number 
of 
Subjects 
Group A Bupivacaine 
Bupivacaine through 
ultrasound guided 
supraclavicular  block 
in patients undergoing 
elective upper limb 
surgeries 
30 
Group B Levobupivacaine 
Levobupivacaine 
through ultrasound 
guided supraclavicular  
block in patients 
undergoing elective 
upper limb surgeries 
30 
STATISTICS  
Descriptive statistics was done for all data and suitable 
statistical tests of comparison were done. Continuous variables 
were analysed with the student’s t-test and categorical variables 
were analysed with the Chi-Square Test and Fisher Exact Test. 
Statistical significance was taken as P < 0.05. The data was 
analysed using EpiInfo software (7.1.0.6 version; Center for disease 
control, USA) and Microsoft Excel 2010. 
 
 67 
SAMPLE SIZE CALCULATION 
Sample size was determined on the basis of a pilot study in 
which the increase in onset and duration of analgesia was measured 
as 15% in Levobupivacaine.  We calculated a minimum sample size 
of 24 patients was required in each group, assuming a type 1 error 
(two-tailed) of 0.05 and a margin of error of 10%. Therefore, the 
final sample selected was n=30 in Group A and n=30 in Group B.  
  
n = t² x p(1-p) 
  m² 
Description 
n = required sample size. t = confidence level at 95% (standard value of 1.96). p = estimated 
prevalence of malnutrition in the project area. m = margin of error at 10% (standard value of 0.05)  
 
n= (1.96)² x 0.15(1-0.15) 
  (0.1)² 
 
n= 3.8146 x 0.1275 
  
0.01 
= 24 per group 
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AGE 
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Age Distribution Bupivacaine % Levobupivacaine % 
≤ 20 years 2 6.67 2 6.67 
21 to30 years 9 30.00 13 43.33 
31 to 40 years 9 30.00 6 20.00 
41 to 50 years 3 10.00 4 13.33 
51 to 60 years 3 10.00 2 6.67 
≥ 60 years 4 13.33 3 10.00 
Total 30 100 30 100 
 
Age Distribution Bupivacaine Levobupivacaine 
N 30 30 
Mean 38.86667 35.36667 
SD 15.2513 14.70745 
P value 
Unpaired t-test 
0.369324091 
By conventional criteria the association between the 
treatment groups and age is considered to be not statistically 
significant since p > 0.05. 
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GENDER 
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Gender  
Distribution 
Bupivacaine % Levobupivacaine % 
Male 23 76.67 22 73.33 
Female 7 23.33 8 26.67 
Total 30 100 30 100 
Chi-square 0.889 
Degrees of freedom 1 
P value 
Chi squared Test 
0.766 
By conventional criteria the association between the 
treatment groups and gender is considered to be not statistically 
significant since p > 0.05. 
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BMI 
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BMI Distribution Bupivacaine % Levobupivacaine % 
Underweight 0 0.00 0 0.00 
Normal 15 50.00 15 50.00 
Overweight 15 50.00 15 50.00 
Obese 0 0.00 0 0.00 
Total 30 100 30 100 
 
BMI Distribution Bupivacaine Levobupivacaine 
N 30 30 
Mean 24.36667 23.56667 
SD 2.988291 2.473073 
P value 
Unpaired t-test 
0.263439717 
By conventional criteria the association between the 
treatment groups and BMI is considered to be not statistically 
significant since p > 0.05. 
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ASA PHYSICAL STATUS CLASSIFICATION SYSTEM 
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ASA Bupivacaine % Levobupivacaine % 
ASA Status 1 21 70.00 23 76.67 
ASA Status 2 9 30.00 7 23.33 
Total 30 100 30 100 
Chi-square 0.341 
Degrees of freedom 1 
P value 
Chi squared Test 
0.559 
By conventional criteria the association between the 
treatments groups and ASA status groups is considered to be not 
statistically significant since p > 0.05. 
 76 
PULSE RATE 
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By conventional criteria the association between the 
treatment groups and effect on pulse rate is considered to be not 
statistically significant since p > 0.05. 
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SYSTOLIC BLOOD PRESSURE 
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By conventional criteria the association between the 
treatment groups and effect on systolic blood pressure is considered 
to be not statistically significant since p > 0.05. 
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DIASTOLIC BLOOD PRESSURE 
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By conventional criteria the association between the 
treatment groups and effect on diastolic blood pressure is 
considered to be not statistically significant since p > 0.05.  
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MEAN ARTERIAL PRESSURE 
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By conventional criteria the association between the treatment groups 
and effect on mean arterial pressure is considered to be not statistically 
significant since p > 0.05. 
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ONSET OF SENSORY BLOCK 
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Onset of Sensory Block Bupivacaine Levobupivacaine 
N 28 29 
Mean 7.41 6.52 
SD 2.58 1.68 
P value 
Unpaired t-test 
0.135828665 
By conventional criteria the association between the 
treatment groups and effect on onset of sensory block is considered 
to be not statistically significant since p > 0.05. 
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ONSET OF MOTOR BLOCK 
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Onset of Motor Block Bupivacaine Levobupivacaine 
N 28 29 
Mean 10.37 9.41 
SD 2.82 2.18 
P value 
Unpaired t-test 
0.163712472 
 
By conventional criteria the association between the 
treatment groups and effect on onset of motor block is considered 
to be not statistically significant since p > 0.05. 
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DURATION OF SENSORY BLOCK 
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Duration of Sensory Block Bupivacaine Levobupivacaine 
N 28 29 
Mean 591.11 746.90 
SD 109.06 98.64 
P value 
Unpaired t-test 
0.00823 
 
By conventional criteria the association between the 
treatment groups and duration of sensory block is considered to be 
statistically significant since p < 0.05. 
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STATISTICAL SIGNIFICANCE 
This indicates that there is a true difference among treatment 
groups and the difference is significant. In simple terms, in patients 
undergoing ultrasound guided supraclavicular  block in elective 
upper limb surgeries, by using levobupivacaine, the duration of 
sensory block is increased to 746.90 ± 98.64 minutes in comparison 
with Bupivacaine which takes 591.11 ± 109.06 minutes with a p -
value of 0.00823 according to unpaired t-test.  
CLINICAL SIGNIFICANCE 
The duration of sensory block was meaningfully more 
(26.35%) in the Levobupivacaine Group compared to the 
Bupivacaine Group by 155.79 minutes. This difference is true and 
significant and has not occurred by chance. 
CONCLUSION  
We conclude that there is real advantage by using 
Levobupivacaine in patients undergoing ultrasound guided 
supraclavicular block in elective upper limb surgeries compared to 
Bupivacaine, which in turn significantly prolongs the duration of 
sensory block thereby proving advantageous in longer duration 
surgeries. 
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DURATION OF MOTOR BLOCK 
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Duration of Motor Block Bupivacaine Levobupivacaine 
N 28 29 
Mean 534.44 678.62 
SD 110.71 89.43 
P value 
Unpaired t-test 
0.0229 
 
By conventional criteria the association between the 
treatment groups and duration of motor block is considered to be 
statistically significant since p < 0.05. 
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STATISTICAL SIGNIFICANCE 
This indicates that there is a true difference among treatment 
groups and the difference is significant. In simple terms, in patients 
undergoing ultrasound guided supraclavicular  blockin elective 
upper limb surgeries, by using levobupivacaine, the duration of 
motor block is increased to 672 .62± 89.43 minutes in comparison 
with Bupivacaine which takes 534.44 ± 110.71 minutes with a p -
value of 0.0229 according to unpaired t-test.  
CLINICAL SIGNIFICANCE 
The duration of motor block was meaningfully more 
(26.98%) in the Levobupivacaine Group compared to the 
Bupivacaine Group by 114.18 minutes. This difference is true and 
significant and has not occurred by chance. 
CONCLUSION  
We conclude that there is real advantage by using 
Levobupivacaine in patients undergoing ultrasound guided 
supraclavicular block in elective upper limb surgeries compared to 
Bupivacaine, which in turnsignificantly prolongs the duration of 
motor block thereby proving advantageous in longer duration 
surgeries. 
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QUALITY OF BLOCK 
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Quality of Block Bupivacaine % Levobupivacaine % 
Unsatisfactory 2 6.67 1 3.33 
Satisfactory 28 93.33 29 96.67 
Failure 0 0.00 0 0.00 
Total 30 100 30 100 
Chi-square 0.351 
Degrees of freedom 1 
P value 
Chi squared Test 
0.554 
By conventional criteria the association between the 
treatment groups and effect on quality of block is considered to be 
not statistically significant since p > 0.05. 
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DISCUSSION 
Peripheral nerve block is a well accepted modality to achieve 
clinical and economic benefits to patients in the perioperative 
period. The benefits includes intra operative surgical anaesthesia, 
post operative analgesia and avoid general anaesthetic 
complications. 
Brachial plexus block provides ideal anaesthetic technique for 
upper limb surgeries. It was first described by Kulenklampf in 
1911. The use of this block has tempered by some technical 
complications. But, interest in supraclavicular block has been 
rekindled by ultrasonography. It localises the brachial plexus 
structures, shows the local anaesthetic distribution and minimises 
the usual technical complications. 
Even though we had ideal technique to block the brachial 
plexus, the ideal local anaesthesia devoid of any toxicity is still on 
quest. Racemic bupivacaine is widely used local anaesthetic agent 
for brachial plexus block
9
. However high dosage or any inadvertent 
intravascular injection may cause fatalities through cardiovascular
10
 
and central nervous system toxicity
10,13
. These toxic effects 
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attributed mainly from dextroenantiomer of R(+)bupivacaine
10,11
. 
So the another enantiomer of levorotatory form of S(+)bupivacaine 
has less toxic effects. So it emerged as safer alternative with similar 
clinical profile as racemic bupivacaine. 
Levobupivacaine has less tendency to cause cardiac toxicity 
due to 
1) Dextroenantiomer R(+)Bupivacaine has 2.4 times higher 
affinity for cardiac sodium channels and dissociates it from 
slowly than levorotatory enantiomer
17
. 
2) Plasma protein binding of levobupivacaine is >97% where as 
bupivacaine is 95% which means availability of drug is less 
in levobupivacaine(<3%) to cause undesired toxic effects
12,13
. 
3) Levobupivacaine has inherent vasoconstrictor activity which 
gives prolonged duration of action and less systemic toxicity. 
Aps Reynolds study demonstrated this postulation
18
. 
Numerous studies have been done to evaluate the efficiency 
of levobupivacaine as anaesthetic agent in respect to onset time, 
duration and analgesic qualities of brachial plexus
14-16
. 
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PRESENT STUDY 
The present study was designed to compare bupivacaine and 
levobupivacaine through ultrasound guided supraclavicular block. 
In the study 60 patients were randomly assigned  into two groups. 
The two groups were comparable with respect to age, sex and body 
mass index(BMI). The difference were statistically insignificant ( p 
value >0.05). 
ONSET OF SENSORY BLOCK 
In the study by Shalini Sardesai et al, the onset of sensory 
block was faster in levobupivacaine group (6.13+/- 0.34min) than 
bupivacaine group (7.59+/-1.43). In the study by Cox et al, the 
onset of sensory block was faster in levobupivacaine group(6min) 
than bupivacaine(8 min). In the present study the onset of sensory 
block is faster in levobupivacaine group(6.52+/-1.68) than 
bupivacaine group(7.41+/-2.58) and p value is 0.1358 so the 
difference is statistically insignificant. 
ONSET OF MOTOR BLOCK 
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In the study by shalini et al, the onset of motor block was 
faster in levobupivacaine group (5.05+/-0.29) than bupivacaine 
group(5.99+/-0.49). In the present study the onset of motor block is 
faster in levobupivacaine group(9.41+/-2.18) than bupivacaine 
group(10.37+/-2.82) and p value is 0.1637 so the difference is 
statistically insignificant. 
DURATION OF SENSORY BLOCK 
In the study by shalini et al, the onset of motor block was 
faster in levobupivacaine group (1036.57+/-93.7) than bupivacaine 
group(871.48+/-174.33). In the present study the onset of sensory 
block in levobupivacaine group(746.90+/-98.64) is faster  than 
bupivacaine group(591.11+/-109.06) and the difference is 
statistically significant. 
DURATION OF MOTOR BLOCK 
In the study by shalini et al, the onset of motor blockwas 
faster in levobupivacaine group (1049.46+/-95.02) than bupivacaine 
group(902.37+/-181.46). In the present study the onset of motor  
block in levobupivacaine group(678.62+/-89.43) is faster than 
bupivacaine group(534.44+/-110.71) and the difference is 
statistically significant. 
QUALITY OF BLOCK 
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In the present study blocks with levobupivacaine group were 
successful in 19 out of 20 cases and in the bupivacaine group were 
successful in 18 out of 20 cases (2 cases of bupivacaine group and 
1 case of levobupivacaine group has considered unsatisfactory 
block and there was no failure case). The difference is statistically 
insignificant.  
COMPLICATION 
There were no complication in both groups during the study.  
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SUMMARY 
On comparing bupivacaine and levobupivacaine in ultrasound 
guided supraclavicular block it was found that 
 The time of onset of sensory and motor blockade was equal in 
both levobupivacaine and bupivacaine group 
 The duration of sensory and motor blockade was prolonged in 
levobupivacaine group than bupivacaine group 
 There were no complications and side effects in both groups 
 The haemodynamics were well maintained in both groups 
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CONCLUSION 
From the study it can be inferred that levobupivacaine is 
longer acting than bupivacaine and its clinical profile is closely 
resembling to bupivacaine. Safe outcome from anaesthesia is the 
main goal for anaesthesiologist so the reduced toxic potential of 
this drug should be considered for regional anaesthesia wherever 
large volume is required. 
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PATIENT CONSENT FORM 
STUDY TITLE 
“A Prospective,   randomized  study comparing bupivacaine 
and levobupivacaine through  ultrasound guided supraclavicular  
block  in patients undergoing elective upper limb surgeries”  
STUDY CENTER 
Institute of Anaesthesiology and Critical Care, 
Madras Medical College, Chennai- 600003. 
Participant name:     
Age:   
Sex:   
I.P.No: 
I confirm that I have understood the purpose of procedure for 
the above study. I have the opportunity to ask the question and all 
my questions and doubts have been answered to my satisfaction.  
I have been explained about the pitfall in the procedure.  I 
have been explained about the safety, advantage and disadvantage 
of the technique. 
I understand that my participation in the study is voluntary 
and that I am free to withdraw at any time without giving any 
reason. 
I understand that investigator, regulatory authorities and the 
ethical committee will not need my permission to look at my health 
records both in respect to current study and any further research 
that may be conducted in relation to it, even if I withdraw from the 
study. I understand that my identity will not be revealed in any 
information released to third parties or published, unless as 
required under the law. I agree not to restrict the use of any data or 
results that arise from the study. 
Time :          
Date :         
Place :         
Patient name    Signature / thumb impression of patient  
Signature of the investigator   Name of the investigator 
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INFORMATION TO PARTICIPANTS 
Investigator    : 
Name of the participant: 
Title: 
“A Prospective,   randomized  study comparing bupivacaine 
and levobupivacaine through  ultrasound guided supraclavicular  
block  in patients undergoing elective upper limb surgeries”  
You are invited to take part in this research study. We have 
got approval from the IEC. You are asked to participate because 
you satisfy the eligibility criteria. We want to compare ultrasound 
guided supraclavicular block using bupivacaine or levobupivacaine, 
in patients undergoing elective upper limb surgeries. 
THE PURPOSE OF THE RESEARCH 
1) To compare ultrasound guided supraclavicular block using 
bupivacaine or levobupivacaine, in patients undergoing 
elective upper limb surgeries with respect to, Intra operative 
hemodynamics, 
2) To compare onset and duration of sensory and motor 
blockade 
STUDY DESIGN 
Prospective, randomized, single blinded , case control study 
60 patients presenting for elective upper limb surgeries were 
randomly assigned to two groups. 
Group1- pre operative ultrasound guided supraclavicular 
block with bupivacaine . 
Group2- pre operative ultrasound guided supraclavicular 
block with levobupivacaine. 
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BENEFITS 
Ultrasound guided supraclavicular block pre operatively, 
reduces intra operative hemodynamics, reduces general anaesthetic 
complication,causes post operative pain  elief. 
DISCOMFORTS AND RISKS 
Discomfort during block- this will be reduced by local 
infiltration. 
Seizures  can occur   – since the drug will be given based on 
calculated maximum allowable dose,  this complication does not 
occur. 
Hypotension ,bradycardia may occur – emergency  drugs are 
readily available 
 
Time :  
Date :  
Place : 
Signature / Thumb Impression of Patient 
Patient Name: 
 
Signature of the Investigator : ____________________________ 
Name of the Investigator : ____________________________ 
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PROFORMA 
ROLL NO: 
DATE: 
NAME:                                                                                          
IP NO: 
AGE:                         SEX: 
HEIGHT:                         WEIGHT:                         BMI:  
DIAGNOSIS: 
SURGICAL PROCEDURE: 
ANAESTHETIC PLAN: 
ANY COMORBID ILLNESS:                                 
H/O ANY DRUG ALLERGY: 
ASA PS:                                                                     MMC: 
 
 HR SBP DBP MAP SpO2 
Baseline      
SCB      
5 mins      
10 mins      
15 mins      
30 mins      
45 mins      
60 mins      
75 mins      
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 HR SBP DBP MAP SpO2 
90 mins      
105 mins      
120 mins      
135 mins      
150 mins      
165 mins      
180 mins      
ONSET OF SENSORY BLOCKADE: 
 
ONSET OF MOTOR BLOCKADE: 
 
DURATION OF SURGERY: 
 
DURATION OF SENSORY BLOCKADE: 
 
DURATION OF MOTOR BLOCKADE: 
 
QUALITY OF BLOCK    
 
SATISFACTORY UNSATISFACTORY FAILURE 
 
SIDE EFFECTS/COMPLICATIONS: 
GROUP A
1 CHINNASAMY 68 M 25 2 88 134 82 99.33 102 93 88 90 82 74 70 71 75 69 68 72 70
2 RAMKUMAR 23 M 21 1 102 124 96 105.33 115 104 96 100 84 75 72 79 82 72
3 RAJAGOPAL 35 M 25 1 84 130 88 102 118 124 96 98 84 78 71 68 78 74 72
4 ELUMALAI 55 M 28 1 68 138 84 102 74 69 68 71 66 64 59 61 64
5 SUBRAMANI 60 M 20 2 71 118 74 88.67 71 68 70 69 76 66 64 66 70 72
6 MUTHUPANDI 35 M 26 1 79 126 84 98 82 80 74 76 72 69 74 78 84 92 98 89 92 96
7 AMUDHA 40 F 24 1 88 138 78 98 92 96 94 84 78 74 80 76 74
8 AYYAPPAN 18 M 19 1 78 118 74 88.67 78 84 74 72 69 66 64 69
9 THIRUPATHY 37 M 25 1 84 130 84 99.33 88 92 84 78 72 69 71 74 76 78 84
10 MOHAMMED 43 M 28 2 78 140 96 110.67 76 80 79 72 68 64 60 70 72
11 DHARSHAN 18 M 19 1 72 124 78 93.33 78 72 68 74 69 66 64 70
12 SUBRAMANI 68 M 25 2 74 138 88 104.67 79 85 74 72 68 64 66 70 68 74 72
13 VARADHARAJAN 39 M 23 1 92 132 92 105.33 106 102 98 92 106 94 92 94 102 112
14 MYMUNISHA 65 F 27 2 84 142 84 103.33 84 82 90 82 78 74 80
15 PRATHAP 28 M 23 1 74 124 74 90.67 78 82 74 70 72 68 62 64 69 72 70
16 RAJ KUMAR 24 M 24 1 72 118 82 94 78 74 68 62 58 62 64 68 78 68 64 62
17 PUNITHA 47 F 29 2 97 144 82 102.67 108 102 98 108 112 104 96 92 84 88
18 NEELIMA 22 F 23 1 74 128 76 93.33 80 82 74 72 76 69 72 78
19 SABARISH 29 M 27 1 80 132 86 101.33 88 82 88 78 76 72 74 79 84
20 MUTHAIYA 56 M 27 2 92 132 78 96 98 90 88 80 73 70 68
21 MALINI 33 F 24 1 78 122 74 90 84 82 78 72 70 64 68 69 72
22 RANGARAJ 64 M 26 2 82 130 82 98 92 98 102 92 84 80 78 82 90 84 90
23 KUMARAVEL 31 M 19 1 74 114 64 80.67 78 72 68 68 74 72 68 74 78 72 70 78 72
24 SENTHIL NATHAN 29 M 21 1 70 118 72 87.33 74 72 68 62 56 54 62 60 54 58 62 68 56 60
25 RAJA SUBRAMANI 24 M 23 1 78 124 82 96 80 82 74 72 68 70 68 74 64 68 62 70 70
26 VAANI 29 F 29 1 98 144 88 106.67 108 112 108 100 98 92 88 84 86 82 90
27 AMREEN 24 F 22 1 80 120 82 94.67 88 82 80 78 72 68 72 70 76
28 PRINCE 38 M 28 2 96 132 94 106.67 102 98 108 104 98 92 96 90 88 82
29 BALA SUBRAMANI 45 M 27 1 84 134 88 103.33 92 96 92 88 82 84 78 72 78 76 72 78 72 80
30 JEEVA 39 M 24 1 78 122 82 95.33 82 88 80 72 78 70 68 74 72 78 70 68
S.No NAME AGE SEX BMI ASA
BASELINE VITALS
PR SBP DBP MAP
INTRA OP PULSE RATE
0 MINS 5 10 15 30 105 120 135 15045 60 75 90 165
S.No NAME AGE SEX BMI ASA
BASELINE VITALS
PR SBP DBP MAP
INTRA OP PULSE RATE
0 MINS 5 10 15 30 105 120 135 15045 60 75 90 165
GROUP B
1 PRATHAP KUMAR 28 M 21 1 78 114 68 83.33 82 80 74 72 70 64 68 70 72 68 78 80
2 MURUGAN 40 M 22 2 74 126 78 94 80 82 74 72 70 68 74 72 70 76 76
3 BACKYANATHAN 50 M 27 2 92 138 88 104.67 96 102 100 94 90 88 82 78 80 78 78
4 POONGAVANAM 22 F 21 1 71 114 70 84.67 78 80 72 70 68 62 64 69 70
5 NIRMALA 35 F 26 1 78 132 86 101.33 88 84 80 80 78 72 76 80 82 82 86 90 92 96
6 ANITHA 25 F 23 1 84 122 80 94 82 89 80 78 72 70 68 70 72 74
7 RAJA 48 M 27 2 92 138 84 102 96 90 88 80 90 82 80 78 80 84 88 80 78
8 CHINNAPONNU 67 F 21 2 76 118 70 86 82 74 78 70 68 62 60 60 64 69 70
9 SATHISH 21 M 19 1 80 122 82 95.33 84 80 78 74 76 72 70 68 70 72 76 74 76
10 ADHILAKSHMI 35 F 25 1 82 134 88 103.33 88 82 78 72 68 66 64 62 68 70
11 MURALI 26 M 23 1 76 122 74 90 78 80 72 68 62 56 58 58 62 64
12 SIVASEELAN 52 M 28 1 80 138 88 104.67 92 98 90 84 82 82 80
13 SIVA 19 M 21 1 72 114 68 83.33 78 72 68 69 72 74 72 70 70 74
14 ELANGOVAN 27 M 23 1 80 122 78 92.67 82 88 80 78 72 68 68 62 68 70 72
15 GANDHI 18 M 27 1 74 138 86 103.33 78 72 72 68 76 74 68 66 70
16 VELMURUGAN 24 M 21 1 72 130 78 95.33 76 80 72 68 62 62 64 68 62 69 70 72 68
17 SHANKAR 24 M 24 1 80 128 80 96 82 80 72 68 68 64 68 70 66 62 70 74 70
18 MURUGARAJ 28 M 23 1 82 124 82 96 88 80 78 72 76 70 68 64 66 70 72
19 JULAIKARA BEE 68 F 22 2 88 122 72 88.67 90 82 80 76 72 68 64 66 68 62
20 DINESH 21 M 22 1 76 118 72 87.33 76 72 68 62 56 58 62 68 64 69 70 72 74 68
21 SURESH 32 M 22 1 82 128 86 100 88 92 80 78 72 76 68 62 69 72 74
22 MANISH 22 M 28 1 80 141 86 104.33 88 82 78 76 74 76 72 80 72 79
23 DEEPA 31 F 23 1 76 124 74 90.67 78 76 72 68 66 64 72 76 71 69 64 66
24 ROBERT 28 M 24 1 82 132 84 100 82 88 92 96 92 90 84 82 80 74 80 84 86 82
25 HARI KUMAR 37 M 25 1 71 118 74 88.67 70 74 70 68 64 62 56 58 59 61 62
26 NAGARAJ 43 M 24 1 78 128 82 97.33 82 88 84 78 72 78 80 84 86
27 PERIYAN 65 M 25 2 86 138 92 107.33 90 92 88 84 88 82 90 86 80 75 76 82
28 MEENAKSHI 56 F 27 2 88 136 82 100 92 90 84 88 80 78 76 80 81 86
29 KUMARAVEL 27 M 20 1 74 118 74 88.67 78 82 80 76 72 68 66 62 70 72 80 72 72
30 TAMBI DURAI 42 M 23 1 88 134 86 102 96 92 88 86 90 82 78 80 82 88
148 138 141 130 129 122 118 110 120 119 112 122 118 104 98 102 98 92 82 74 76 72 79
124 128 122 120 115 104 110 102 110 108 94 100 92 84 72 68 70 76 71 69
148 144 140 138 124 118 120 128 114 118 126 96 102 98 88 78 72 74 70 76 71
131 122 124 120 118 116 126 124 110 88 82 76 80 74 76 72 69 70
118 126 120 116 110 108 110 119 104 109 76 79 72 70 69 66 70 74 77 72
99 130 126 128 118 116 120 110 108 102 106 96 98 94 99 102 80 78 74 76 72 69 66 64 69 62
142 144 136 130 126 122 124 120 112 84 90 88 82 88 78 75 74 74
120 116 112 108 106 102 110 114 74 78 72 80 74 72 68 72
138 136 132 128 122 118 112 118 124 130 128 88 92 80 78 72 74 76 78 72 84
142 146 134 128 134 136 132 124 130 98 102 98 96 88 84 82 80 78
126 130 122 114 118 110 108 114 82 74 76 72 68 70 74 72
146 142 134 130 122 124 128 120 118 124 122 88 96 92 84 80 74 78 72 80 76
134 142 144 148 134 132 126 130 134 140 92 96 102 98 92 88 94 86 82 94
144 148 138 134 130 123 128 92 94 88 84 82 80 90
128 134 122 118 112 108 110 114 119 114 108 78 82 84 74 70 76 72 70 76 72
124 122 118 119 120 114 108 109 116 112 124 128 80 78 82 84 74 76 72 80 78 76
148 142 146 138 140 132 136 128 136 128 88 92 94 84 80 86 78 82 86 80
124 132 130 128 122 118 114 120 78 86 82 78 74 72 76 78
140 138 132 128 122 120 126 122 128 86 82 78 72 76 79 84 78 82
138 124 122 120 129 134 136 78 72 68 70 74 78 84
124 128 120 118 114 110 122 118 120 84 82 78 74 68 74 70 69 68
138 142 136 132 128 122 118 124 128 134 138 80 88 80 74 78 68 76 72 78 82
114 120 112 110 108 102 106 98 102 104 96 98 108 80 78 74 68 72 64 62 60 64 68
64 122 126 118 110 112 114 108 102 109 112 116 114 108 114 112 82 78 74 68 66 64 68 69 70 72
124 128 130 122 118 112 114 116 110 112 118 108 109 82 88 80 78 72 74 70 68 64 62
148 152 142 138 132 128 122 127 128 134 128 92 98 102 96 92 84 92 90 88 86
122 124 118 112 116 110 108 109 112 82 80 74 72 68 64 68 72 70
134 140 138 132 128 126 122 129 130 128 92 90 88 88 82 86 92 84 82 80
138 132 128 122 118 118 116 112 110 109 117 116 122 120 84 82 78 72 74 70 68 72 70 69
128 132 130 128 122 120 118 119 120 111 120 118 80 78 74 80 72 70 68 74 72 82
INTRA OP PULSE RATE INTRA OP SBP
0 MINS 5 10 15 30 45 60 75 90 105 120180 30 45 60 75 90135 150 165 180 105
INTRA OP DBP
0 MINS 5 10 15
INTRA OP PULSE RATE INTRA OP SBP
0 MINS 5 10 15 30 45 60 75 90 105 120180 30 45 60 75 90135 150 165 180 105
INTRA OP DBP
0 MINS 5 10 15
128 122 124 120 116 114 110 108 102 110 116 124 82 76 68 72 70 69 72 66 68 72
120 132 124 122 118 110 112 114 116 110 108 84 82 84 78 74 72 68 70 72 76
142 144 138 132 134 128 122 129 120 126 132 96 92 88 86 82 78 72 76 80 72
118 112 104 100 102 108 112 106 102 74 78 72 68 64 69 74 72 72
90 134 139 140 134 128 122 128 122 120 116 118 110 114 112 116 84 88 82 78 74 72 68 70 70 66
128 122 120 116 118 113 117 110 118 120 86 82 78 78 72 68 70 69 74 68
142 144 138 132 134 130 128 130 136 138 130 129 138 96 102 100 98 92 88 86 84 89 82
114 118 120 112 108 102 104 108 114 112 110 76 72 72 68 64 66 62 68 68 72
124 126 122 118 112 110 108 112 116 108 114 116 120 82 88 80 78 72 74 72 70 68 68
138 134 134 128 122 120 116 112 118 110 92 88 84 80 78 70 72 74 76 79
122 129 120 114 116 110 108 110 112 110 80 74 72 68 64 66 70 72 68 66
142 138 140 134 130 130 136 92 94 88 82 86 80 82
124 128 122 118 110 110 116 114 108 112 82 84 78 72 70 68 66 70 73 74
130 132 128 122 120 118 116 112 119 122 127 80 82 78 72 76 74 73 70 68 70
140 142 138 134 128 130 129 122 126 90 88 84 82 78 72 70 76 80
130 128 122 124 120 118 116 112 114 118 116 110 120 80 78 78 72 68 66 72 74 68 68
130 128 122 118 120 116 114 110 116 114 120 121 124 82 80 78 76 70 68 72 74 76 76
128 122 120 118 114 116 110 108 109 115 120 80 82 78 72 68 66 68 74 69 70
126 122 120 116 118 112 112 104 108 116 80 74 68 62 64 66 69 64 70 68
122 118 116 112 110 122 124 118 110 108 106 108 114 116 78 80 72 68 72 74 76 70 68 70
136 132 129 127 124 118 110 112 119 124 121 84 78 82 76 76 72 74 68 76 74
138 146 132 136 130 128 126 122 129 132 89 91 88 84 86 82 78 80 76 80
129 130 124 122 120 116 110 118 112 106 109 111 80 78 76 72 70 74 68 72 78 70
134 138 141 144 142 138 134 128 127 128 131 136 134 139 86 92 90 94 82 84 82 78 84 83
118 124 122 120 116 114 112 110 108 108 114 74 78 72 70 68 69 64 66 62 62
128 134 132 130 126 124 128 130 124 78 82 76 72 78 70 68 70 72
142 144 138 138 134 128 130 126 134 138 140 144 88 92 96 88 84 86 82 78 76 80
140 136 138 132 128 126 124 120 119 131 88 82 80 78 76 72 80 80 76 74
124 122 118 114 110 108 106 108 114 116 120 122 126 82 74 78 72 68 69 64 71 72 69
145 146 142 138 132 126 132 128 122 129 89 92 88 84 86 82 78 82 76 79
69 70 74 118.7 111.33 115 108.67 104.33 95.333 88.67 87.33 88 92.33 83.33 87.33 88.67
104 109.33 102 96 86.33 80 83.33 84.67 84 82
70 113.33 116 112 104.67 93.33 87.33 89.33 89.33 88.7 86.67 88.67
102.33 95.33 92 93.33 88.67 89.33 90 87.33 83.33
90 94.67 88 85.33 82.67 80 83.33 89 86 84.33
56 60 54 64 62 96.67 94 92 90 86.67 86 80.67 78.67 80 76.67 69.33 72.67 67.33 75.67 75.33
103.33 108 104 98 100.67 92.67 91.33 89.33 86.67
89.33 90.67 85.33 89.33 84.67 82 82 86
88 104.67 106.67 97.33 94.67 88.67 88.67 88 91.33 89.33 99.33 101.33
112.67 116.67 110 106.67 103.33 101.33 98.67 94.67 95.33
96.67 92.67 91.33 86 84.67 83.33 85.33 86
80 107.33 111.33 106 99.33 94 90.67 94.67 88 92.67 92 94
106 111.33 116 114.67 106 102.67 104.67 100.67 99.33 109.33
109.33 112 104.67 100.67 98 94.33 102.67
79 94.67 99.33 96.67 88.67 84 86.67 84.67 84.67 90.33 86.00 88.67
78 74 94.67 92.67 94 95.67 89.33 88.67 84 89.67 90.67 88 93.33 92
108 108.67 111.33 102 100 101.33 97.33 97.33 102.67 96
93.33 101.33 98 94.67 90 87.33 88.67 92
104 100.67 96 90.67 91.33 92.67 98 92.67 97.33
98 89.33 86 86.67 92.33 96.67 101.33
97.33 97.33 92 88.67 83.33 86 87.33 85.33 85.33
88 99.33 106 98.67 93.33 94.67 86 90 89.33 94.67 99.33 104.67
72 66 70 91.33 92 86.67 82 84 76.67 76.67 72.67 76.67 80 80 76.67 82.67
68 68 70 72 76 95.33 94 88.67 82 81.33 80.67 81.33 80 83 85.33 84 83.33 82.67 86 88
69 72 70 96 101.33 96.67 92.67 87.33 86.67 84.67 84 79.33 78.67 85.33 84 83
92 110.67 116 115.33 110 105.33 98.67 102 102.33 101.33 102 104
95.33 94.67 88.67 85.33 84 79.33 81.33 84.33 84
106 106.67 104.67 102.67 97.33 99.33 102 99 98 96
74 70 68 72 102 98.67 94.67 88.67 88.67 86 84 85.33 83.33 82.33 88.33 85.33 86 88
84 78 96 96 92.67 96 88.67 86.67 84.67 89 88 91.67 96 91.33
60120 135 150
INTRA OP DBP
75 90 105 120165 180 0 MINS 5 10 15 135 150 165 180
INTRA OP MAP
30 45
60120 135 150
INTRA OP DBP
75 90 105 120165 180 0 MINS 5 10 15 135 150 165 180
INTRA OP MAP
30 45
74 78 97.33 91.33 86.67 88 85.33 84 84.67 80 79.33 84.67 88 93.33
79 96 98.67 97.33 92.67 88.67 84.67 82.67 84.67 86.67 87.33 88.67
74 111.33 109.33 104.67 101.33 99.33 94.67 88.67 93.67 93.33 90 93.33
88.67 89.33 82.67 78.67 76.67 82 86.67 83.33 82
70 62 64 62 68 100.67 105 101.33 96.67 92 88.67 88 87.33 86.67 82.67 86 78 80.67 78.67 84
100 95.33 92 90.67 87.33 83 85.67 82.67 88.67 85.33
90 90 94 111.33 116 112.67 109.33 106 102 100 99.33 104.67 100.67 103.33 103 108.67
70 88.67 87.33 88 82.67 78.67 78 76 81.33 83.33 85.33 83.33
70 72 76 96 100.67 94 91.33 85.33 86 84 84 84 81.33 84.67 86.67 90.67
107.33 103.33 100.67 96 92.67 86.67 86.67 86.67 90 89.33
94 92.33 88 83.33 81.33 80.67 82.67 84.67 82.67 80.67
108.67 108.67 105.33 99.33 100.67 96.67 100
96 98.67 92.67 87.33 83.33 82 82.67 84.67 84.67 86.67
72 96.67 98.67 94.67 88.67 90.67 88.67 87.33 84 85 87.33 90.33
106.67 106 102 99.33 94.67 91.33 89.67 91.33 95.33
69 70 71 96.67 94.67 92.67 89.33 85.33 83.33 86.67 86.67 83.33 84.67 84.67 83.33 87.33
78 74 72 98 96 92.67 90 86.67 84 86 86 89.33 88.67 92 89.67 89.33
72 96 95.33 92 87.33 83.33 82.67 82 85.33 82.33 85 88
95.33 90 85.33 80 82 81.33 83.33 77.33 82.67 84
72 70 69 66 92.67 92.67 86.67 82.67 84.67 90 92 86 82 82.67 83.33 82.67 84 82.67
72 101.33 96 97.67 93 92 87.33 86 82.67 90.33 90.67 88.33
105.33 109.33 102.67 101.33 100.67 97.33 94 94 93.67 97.33
70 72 96.33 95.33 92 88.67 86.67 88 82 87.33 89.33 82 83 85
88 91 90 94 102 107.33 107 110.67 102 102 99.33 94.67 98.33 98 102.33 106 104.67 109
68 88.67 93.33 88.67 86.67 84 84 80 80.67 77.33 77.33 83.33
94.67 99.33 94.67 91.33 94 88 88 90 89.33
79 80 106 109.33 110 104.67 100.67 100 98 94 95.33 99.33 99.33 101.33
105.33 100 99.33 96 93.33 90 94.67 93.33 90.33 93.00
64 70 71 96 90 91.33 86 82 82 78 83.33 86.00 84.67 82.67 87.33 89.33
107.67 110 106 102 101.33 96.67 96 97.33 91.33 95.67
ONSET DURATION ONSET DURATION
6 600 8 510 SATISFACTORY BLOCK NO
9 720 11 690 SATISFACTORY BLOCK NO
6 540 9 450 SATISFACTORY BLOCK NO
7 660 8 630 SATISFACTORY BLOCK NO
4 750 6 690 SATISFACTORY BLOCK NO
8 510 10 450 SATISFACTORY BLOCK NO
7 600 8 540 SATISFACTORY BLOCK NO
5 780 8 750 SATISFACTORY BLOCK NO
9 510 15 480 SATISFACTORY BLOCK NO
6 660 9 630 SATISFACTORY BLOCK NO
5 720 8 630 SATISFACTORY BLOCK NO
9 510 15 450 SATISFACTORY BLOCK NO
converted to General 
Anaesthesia UNSATISFACTORY BLOCK NO
6 840 9 780 SATISFACTORY BLOCK NO
6 690 10 600 SATISFACTORY BLOCK NO
8 540 12 480 SATISFACTORY BLOCK NO
converted to General 
Anaesthesia UNSATISFACTORY BLOCK NO
5 600 9 540 SATISFACTORY BLOCK NO
12 540 15 480 SATISFACTORY BLOCK NO
6 630 9 570 SATISFACTORY BLOCK NO
9 450 12 390 SATISFACTORY BLOCK NO
6 600 10 510 SATISFACTORY BLOCK NO
4 660 6 600 SATISFACTORY BLOCK NO
6 600 9 510 SATISFACTORY BLOCK NO
9 570 12 510 SATISFACTORY BLOCK NO
10 540 12 510 SATISFACTORY BLOCK NO
8 600 10 570 SATISFACTORY BLOCK NO
16 540 18 450 SATISFACTORY BLOCK NO
8 600 10 540 SATISFACTORY BLOCK NO
6 600 10 510 SATISFACTORY BLOCK NO
SENSORY MOTOR RESCUE  ANALGESIA QUALITY OF BLOCK
SIDE EFFECTS/ 
complication
ONSET DURATION ONSET DURATION
SENSORY MOTOR RESCUE  ANALGESIA QUALITY OF BLOCK
SIDE EFFECTS/ 
complication
7 810 10 780 SATISFACTORY BLOCK NO
6 720 9 660 SATISFACTORY BLOCK NO
4 780 6 750 SATISFACTORY BLOCK NO
6 720 8 690 SATISFACTORY BLOCK NO
8 630 15 570 SATISFACTORY BLOCK NO
5 840 7 780 SATISFACTORY BLOCK NO
6 750 8 690 SATISFACTORY BLOCK NO
7 780 10 720 SATISFACTORY BLOCK NO
5 780 8 750 SATISFACTORY BLOCK NO
7 690 10 600 SATISFACTORY BLOCK NO
4 1080 6 960 SATISFACTORY BLOCK NO
6 690 8 630 SATISFACTORY BLOCK NO
6 690 10 630 SATISFACTORY BLOCK NO
8 750 12 690 SATISFACTORY BLOCK NO
9 780 12 720 SATISFACTORY BLOCK NO
5 720 8 660 SATISFACTORY BLOCK NO
6 690 9 630 SATISFACTORY BLOCK NO
6 750 9 690 SATISFACTORY BLOCK NO
12 780 15 720 SATISFACTORY BLOCK NO
6 720 8 600 SATISFACTORY BLOCK NO
7 690 10 630 SATISFACTORY BLOCK NO
9 660 12 570 SATISFACTORY BLOCK NO
5 780 8 750 SATISFACTORY BLOCK NO
converted to General 
Anaesthesia UNSATISFACTORY BLOCK NO
6 720 8 660 SATISFACTORY BLOCK NO
8 660 10 600 SATISFACTORY BLOCK NO
5 540 9 510 SATISFACTORY BLOCK NO
6 720 10 630 SATISFACTORY BLOCK NO
6 780 8 690 SATISFACTORY BLOCK NO
8 690 10 600 SATISFACTORY BLOCK NO
